With minimally invasive structural procedures crowding out their surgical counterparts, how are physicians and hospitals preparing for the new reality? 

French medtech startup Robocath has raised 5 million euros—the equivalent of $5.5 million in U.S. currency—in support of its cardiovascular robotics system, the company announced this month.

Researchers have uncovered evidence of a global “epidemiological transition” that’s seeing cancer overtake cardiovascular disease as the biggest killer in developed countries, Reuters reports.

The U.S. FDA this month granted Fast Track designation to AstraZeneca for the development of Farxiga, or dapagliflozin. 

Cardiology compensation jumped 4.4% while productivity remained relatively stagnant between 2017 and 2018, AMGA reported in its 32nd annual Medical Group Compensation and Productivity Survey.

Malpractice litigation is a risk that’s inherent to acute stroke care, Mount Sinai researchers reported in Stroke this month—and while just over half of cases get resolved, the remainder can cost medical centers millions in payouts.

Illinois Gov. JB Pritzker signed House Bill 3435 this month, CNN reported—a law that will require insurance companies to cover all costs of EpiPen injections for anyone under 18 years old.

CMS this month announced that, after continued analysis of Abiomed’s Impella RP system, it will no longer be cutting its reimbursement rate for the heart pump in October.